老年人营养补充剂和处方药之间的药理学相互作用:综合性审查
Gichin Changaramkumarath1, Jane M Abucha2, Mekdes M Wollel3
1Internal Medicine, Chongqing Medical University, Chongqing, CHN.
Cureus
|October 17, 2025
概括
老年人经常结合补充剂和药物,增加相互作用风险. 改善沟通和查对于防止这种不断增长的人口的不良影响至关重要.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 全球人口老龄化正在经历多药和补充剂使用的增加.
- 老年人经常将处方药与食补充剂结合起来,冒着不良事件的风险.
- 医疗保健提供者经常忽视补充剂药物相互作用,导致可预防的伤害.
研究的目的:
- 审查老年人补充剂和药物使用的交叉点.
- 综合有关老年人补充剂与药物相互作用的流行率和风险的证据.
- 发现患者与医疗服务提供者之间关于补充剂使用的沟通缺口.
主要方法:
- 近三十年来对16项国际研究进行了系统审查.
- 对老年人同时使用补充剂和药物的分析.
- 检查报告的不良相互作用和促成因素.
主要成果:
- 同时使用补充剂和药物范围从23%到82.5%.
- 与抗血栓药物 (例如,华法林,银杏) 和影响吸收的矿物质 (例如,,勒沃西) 确定的高风险相互作用.
- 患者与医疗服务提供者之间的沟通缺口显著加剧了互动风险.
结论:
- 需要积极的临床策略,包括标准化查和患者教育.
- 药剂师主导的药物管理可以减轻风险.
- 需要进一步的纵向和基于干预的研究,特别是来自全球不同地区的研究.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
233
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233


